Search Results - "Bellamy, N."

Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report by DROSSMAN, Douglas A, CHANG, L, BELLAMY, N, GALLO-TORRES, H. E, LEMBO, A, MEARIN, F, NORTON, N. J, WHORWELL, P

“…The concept of severity in irritable bowel syndrome (IBS) is clinically recognized and operative in diagnostic decision making and treatment planning. Yet,…”
Get full text

A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis – the HUMOR trial by Aitken, D., Laslett, L.L., Pan, F., Haugen, I.K., Otahal, P., Bellamy, N., Bird, P., Jones, G.

“…To assess the efficacy of adalimumab in patients with erosive hand osteoarthritis (OA). Patients >50 years old, meeting the American College of Rheumatology…”
Get full text

Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study by Tubach, F., Ravaud, P., Martin‐Mola, E., Awada, H., Bellamy, N., Bombardier, C., Felson, D. T., Hajjaj‐Hassouni, N., Hochberg, M., Logeart, I., Matucci‐Cerinic, M., van de Laar, M., van der Heijde, D., Dougados, M.

“…Objective To estimate the minimum clinically important improvement (MCII) and patient acceptable symptom state (PASS) values for 4 generic outcomes in 5…”
Get full text

Intraarticular corticosteroid for treatment of osteoarthritis of the knee by Bellamy, N, Campbell, J, Robinson, V, Gee, T, Bourne, R, Wells, G

“…Osteoarthritis (OA) is a common joint disorder. In the knee, injections of corticosteroids into the joint (intra-articular (IA)) may relieve inflammation, and…”
Get more information

Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement by Tubach, F, Ravaud, P, Baron, G, Falissard, B, Logeart, I, Bellamy, N, Bombardier, C, Felson, D, Hochberg, M, van der Heijde, D, Dougados, M

“…Background: In clinical trials, at the group level, results are usually reported as mean and standard deviation of the change in score, which is not meaningful…”
Get full text

OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited by Pham, T, van der Heijde, D, Altman, R.D, Anderson, J.J, Bellamy, N, Hochberg, M, Simon, L, Strand, V, Woodworth, T, Dougados, M

“…Background: The OARSI Standing Committee for Clinical Trials Response Criteria Initiative had developed two sets of responder criteria to present the results…”
Get full text

Viscosupplementation for the treatment of osteoarthritis of the knee by Bellamy, N, Campbell, J, Robinson, V, Gee, T, Bourne, R, Wells, G

“…Osteoarthritis (OA) is the most prevalent chronic joint disorder worldwide and is associated with significant pain and disability. To assess the effects of…”
Get more information

Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state by Tubach, F, Ravaud, P, Baron, G, Falissard, B, Logeart, I, Bellamy, N, Bombardier, C, Felson, D, Hochberg, M, van der Heijde, D, Dougados, M

“…Background: The patient acceptable symptom state (PASS) is the value beyond which patients can consider themselves well. This concept can help in interpreting…”
Get full text

Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee by Campbell, J., B.A, Bellamy, N., M.D., D.Sc, Gee, T., Ph.D

“…Summary Objective To explore reasons for discrepant results between systematic reviews (SR)/meta-analyses (MA) of the efficacy and safety of hyaluronic…”
Get full text

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations by Turk, Dennis C, Dworkin, Robert H, Allen, Robert R, Bellamy, Nicholas, Brandenburg, Nancy, Carr, Daniel B, Cleeland, Charles, Dionne, Raymond, Farrar, John T, Galer, Bradley S, Hewitt, David J, Jadad, Alejandro R, Katz, Nathaniel P, Kramer, Lynn D, Manning, Donald C, McCormick, Cynthia G, McDermott, Michael P, McGrath, Patrick, Quessy, Steve, Rappaport, Bob A, Robinson, James P, Royal, Mike A, Simon, Lee, Stauffer, Joseph W, Stein, Wendy, Tollett, Jane, Witter, James

“…Objective. To provide recommendations for the core outcome domains that should be considered by investigators conducting clinical trials of the efficacy and…”
Get full text

Dimensionality and clinical importance of pain and disability in hand osteoarthritis: Development of the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index by Bellamy, N., Campbell, J., Haraoui, B., Buchbinder, R., Hobby, K., Roth, J.H., MacDermid, J.C.

“…Objective To develop a reliable, valid, and responsive self-administered questionnaire to probe pain, stiffness and physical disability in patients with…”
Get full text

Viscosupplementation for the treatment of osteoarthritis of the knee by Bellamy, N, Campbell, J, Robinson, V, Gee, T, Bourne, R, Wells, G

“…Osteoarthritis (OA) is the most prevalent chronic joint disorder worldwide and is associated with significant pain and disability. To assess the effects of…”
Get more information

Science of assessment by Bellamy, N

“…Psoriatic arthritis is a multisystem disorder which, from a measurement standpoint, demands consideration of its cutaneous manifestations and both axial and…”
Get full text

A randomised double-blind placebo-controlled crossover trial of humira (adalimumab) for erosive hand osteoarthritis: the humor trial by Aitken, D, Pan, F, Laslett, L, Bellamy, N, Bird, P, Haugen, I, Jones, G

Get full text

Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis by Ehrich, E W, Davies, G M, Watson, D J, Bolognese, J A, Seidenberg, B C, Bellamy, N

“…To determine the minimal perceptible clinical improvement (MPCI) in patients with osteoarthritis (OA) with the Western Ontario and McMaster Universities…”
Get more information

Progression of hand osteoarthritis over 2 years: a clinical and radiological follow-up study by Botha-Scheepers, S, Riyazi, N, Watt, I, Rosendaal, F R, Slagboom, E, Bellamy, N, Breedveld, F C, Kloppenburg, M

“…To investigate the course of hand osteoarthritis over 2 years by currently available outcome measures. 189 participants of the Genetics, Arthrosis and…”
Get more information

Topical diclofenac and its role in pain and inflammation: an evidence-based review by Zacher, J., Altman, R., Bellamy, N., Brühlmann, P., Da Silva, J., Huskisson, E., Taylor, R. S.

“…ABSTRACT Objective: Topical diclofenac is widely used in the treatment of pain and inflammation. This comprehensive review assesses the safety and efficacy of…”
Get full text

Outcome measurement in osteoarthritis clinical trials by Bellamy, N

“…The clinical assessment of outcome in osteoarthritis (OA) clinical trials is highly dependent on the use of valid, reliable, and responsive measurement…”
Get more information

A cross-sectional study of the association between Heberden's nodes, radiographic osteoarthritis of the hands, grip strength, disability and pain by Jones, G., Cooley, H.M., Bellamy, N.

“…Objective To describe the associations between hand osteoarthritis (OA), pain and disability in males and females and to further validate the…”
Get full text

DEVELOPMENT AND APPLICATION OF RESPONDER CRITERIA, STATE-ATTAINMENT CRITERIA AND NORMATIVE VALUES IN OSTEOARTHRITIS by Bellamy, N

Get full text